Projected Income Statement: Givaudan SA

Forecast Balance Sheet: Givaudan SA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 4,390 4,530 4,305 4,002 3,678 3,335 2,936 2,592
Change - 3.19% -4.97% -7.04% -8.1% -9.33% -11.96% -11.72%
Announcement Date 28/01/22 25/01/23 25/01/24 24/01/25 29/01/26 - - -
1CHF in Million
Estimates

Cash Flow Forecast: Givaudan SA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 256 304 275 293 305 316.7 334 351.8
Change - 18.75% -9.54% 6.55% 4.1% 3.84% 5.45% 5.33%
Free Cash Flow (FCF) 1 1,032 644 1,098 1,332 1,207 1,149 1,211 1,238
Change - -37.6% 70.5% 21.31% -9.38% -4.85% 5.44% 2.2%
Announcement Date 28/01/22 25/01/23 25/01/24 24/01/25 29/01/26 - - -
1CHF in Million
Estimates

Forecast Financial Ratios: Givaudan SA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 22.17% 20.74% 21.3% 23.81% 23.43% 23.86% 23.98% 23.93%
EBIT Margin (%) 16.29% 15.62% 16.14% 18.81% 18.48% 19.02% 19.36% 19.47%
EBT Margin (%) 14.44% 13.04% 14.3% 17.71% 17.47% 17.45% 17.95% 17.93%
Net margin (%) 12.28% 12.03% 12.91% 14.71% 14.33% 14.66% 15.19% 15.46%
FCF margin (%) 15.44% 9.05% 15.88% 17.97% 16.15% 15.21% 15.32% 15%
FCF / Net Income (%) 125.7% 75.23% 122.96% 122.2% 112.7% 103.74% 100.89% 96.97%

Profitability

        
ROA 7.44% 7.46% 7.89% 9.39% 8.94% 9.41% 9.94% 10.09%
ROE 22.13% 20.98% 21.71% 25.43% 23.5% 23.47% 23.12% 22.15%

Financial Health

        
Leverage (Debt/EBITDA) 2.96x 3.07x 2.92x 2.27x 2.1x 1.85x 1.55x 1.31x
Debt / Free cash flow 4.25x 7.03x 3.92x 3x 3.05x 2.9x 2.42x 2.09x

Capital Intensity

        
CAPEX / Current Assets (%) 3.83% 4.27% 3.98% 3.95% 4.08% 4.19% 4.23% 4.26%
CAPEX / EBITDA (%) 17.27% 20.6% 18.67% 16.6% 17.42% 17.58% 17.62% 17.81%
CAPEX / FCF (%) 24.81% 47.2% 25.05% 22% 25.27% 27.57% 27.58% 28.42%

Items per share

        
Cash flow per share 1 138.6 102.5 148.7 175.4 163 148.8 163.1 173
Change - -26.1% 45.14% 17.93% -7.05% -8.74% 9.62% 6.12%
Dividend per Share 1 66 67 68 68 70 73.88 75.89 78.57
Change - 1.52% 1.49% 0% 2.94% 5.54% 2.72% 3.52%
Book Value Per Share 1 422.9 458.7 432.4 495.8 491.7 532.8 584.9 637.9
Change - 8.46% -5.72% 14.65% -0.82% 8.35% 9.79% 9.06%
EPS 1 88.37 92.51 96.47 117.6 115.5 120.4 130.5 137.8
Change - 4.68% 4.28% 21.93% -1.84% 4.3% 8.35% 5.64%
Nbr of stocks (in thousands) 9,228 9,227 9,227 9,227 9,229 9,229 9,229 9,229
Announcement Date 28/01/22 25/01/23 25/01/24 24/01/25 29/01/26 - - -
1CHF
Estimates
2026 *2027 *
P/E ratio 23.3x 21.5x
PBR 5.27x 4.8x
EV / Sales 3.87x 3.65x
Yield 2.63% 2.7%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
2,808.00CHF
Average target price
3,446.87CHF
Spread / Average Target
+22.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GIVN Stock
  4. Financials Givaudan SA